Back to Search Start Over

Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies.

Authors :
Zhang X
Spiegelman D
Baglietto L
Bernstein L
Boggs DA
van den Brandt PA
Buring JE
Gapstur SM
Giles GG
Giovannucci E
Goodman G
Hankinson SE
Helzlsouer KJ
Horn-Ross PL
Inoue M
Jung S
Khudyakov P
Larsson SC
Lof M
McCullough ML
Miller AB
Neuhouser ML
Palmer JR
Park Y
Robien K
Rohan TE
Ross JA
Schouten LJ
Shikany JM
Tsugane S
Visvanathan K
Weiderpass E
Wolk A
Willett WC
Zhang SM
Ziegler RG
Smith-Warner SA
Source :
The American journal of clinical nutrition [Am J Clin Nutr] 2012 Mar; Vol. 95 (3), pp. 713-25. Date of Electronic Publication: 2012 Jan 25.
Publication Year :
2012

Abstract

Background: Epidemiologic studies examining associations between carotenoid intakes and risk of breast cancer by estrogen receptor (ER) and progesterone receptor (PR) status are limited.<br />Objective: We investigated these associations in a pooled analysis of 18 cohort studies.<br />Design: Of 1,028,438 participants followed for a maximum follow-up of 26 y across studies, 33,380 incident invasive breast cancers were identified. Study-specific RRs and 95% CIs were estimated by using Cox proportional hazards regression and then pooled by using a random-effects model.<br />Results: α-Carotene, β-carotene, and lutein/zeaxanthin intakes were inversely associated with the risk of ER-negative (ER-) breast cancer (pooled multivariable RRs of the comparison between the highest and lowest quintiles): α-carotene (0.87; 95% CI: 0.78, 0.97), β-carotene (0.84; 95% CI: 0.77, 0.93), and lutein/zeaxanthin (0.87; 95% CI: 0.79, 0.95). These variables were not inversely associated with the risk of ER-positive (ER+) breast cancer (pooled multivariable RRs for the same comparison): α-carotene (1.04; 95% CI: 0.99, 1.09), β-carotene (1.04; 95% CI: 0.98, 1.10), and lutein/zeaxanthin (1.00; 95% CI: 0.93, 1.07). Although the pooled RRs for quintile 5 for β-cryptoxanthin were not significant, inverse trends were observed for ER- and ER+ breast cancer (P-trend ≤ 0.05). Nonsignificant associations were observed for lycopene intake. The associations were largely not appreciably modified by several breast cancer risk factors. Nonsignificant associations were observed for PR-positive and PR-negative breast cancer.<br />Conclusions: Intakes of α-carotene, β-carotene, and lutein/zeaxanthin were inversely associated with risk of ER-, but not ER+, breast cancer. However, the results need to be interpreted with caution because it is unclear whether the observed association is real or due to other constituents in the same food sources.

Details

Language :
English
ISSN :
1938-3207
Volume :
95
Issue :
3
Database :
MEDLINE
Journal :
The American journal of clinical nutrition
Publication Type :
Academic Journal
Accession number :
22277553
Full Text :
https://doi.org/10.3945/ajcn.111.014415